Arcutis Biotherapeutics, Inc.
ARQTAs of the close on Sep 25, 2026
Price
$26.92
Market cap
$3.38B
P/E (diluted TTM)
—
The quarterly per-share figures could not be confirmed against net income
EPS (TTM)
—
The quarterly per-share figures could not be confirmed against net income
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Arcutis Biotherapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 7 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 17, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Driehaus Capital Management LLC | 2026-03-31 | 2,226,029 | $52.4M | SEC filing |
| Tejara Capital Ltd | 2026-03-31 | 166,191 | $3.92M | SEC filing |
| Rachor Investment Advisory Services, LLC | 2026-03-31 | 269 | $6.34K | SEC filing |
| Campbell & CO Investment Adviser LLC | 2026-03-31 | 31,544 | $743K | SEC filing |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 2026-03-31 | 175,870 | $4.14M | SEC filing |
| ALLIANCEBERNSTEIN L.P. | 2026-03-31 | 118,223 | $3.43M | SEC filing |
| QUADRANT CAPITAL GROUP LLC | 2026-03-31 | 1,550 | $36.5K | SEC filing |
| PSP Research LLC | 2026-03-31 | 19,700 | $464K | SEC filing |
| Legal & General Group Plc | 2026-03-31 | 84,877 | $2M | SEC filing |
| WELLINGTON MANAGEMENT GROUP LLP | 2026-03-31 | 44,373 | $1.05M | SEC filing |
| CITIGROUP INC | 2026-03-31 | 48,337 | $1.14M | SEC filing |
| Financiere des Professionnels - Fonds d'investissement inc. | 2026-03-31 | 12,434 | $293K | SEC filing |
| STATE STREET CORP | 2026-03-31 | 6,296,197 | $148M | SEC filing |
| Engineers Gate Manager LP | 2026-03-31 | 65,977 | $1.55M | SEC filing |
| GW&K Investment Management, LLC | 2026-03-31 | 988,387 | Not shown | SEC filing |
| Vontobel Holding Ltd. | 2026-03-31 | 34,610 | $815K | SEC filing |
| Physician Wealth Advisors, Inc. | 2026-03-31 | 46 | $1.08K | SEC filing |
| Parkside Financial Bank & Trust | 2026-03-31 | 119 | $2.8K | SEC filing |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 2026-03-31 | 154,422 | $3.64M | SEC filing |
| AMERIPRISE FINANCIAL INC | 2026-03-31 | 101,674 | $2.4M | SEC filing |
- Each value is checked against Arcutis Biotherapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Arcutis Biotherapeutics, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Arcutis Biotherapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-03-02 · Leonard Keith R: Larger than 118 of the 123 other insider sales of Common Stock on file. SEC filing
- 2026-03-02 · Watanabe Todd: Larger than 117 of the 123 other insider sales of Common Stock on file. SEC filing
- 2025-11-24 · LIN SUE-JEAN: Larger than 114 of the 123 other insider sales of Common Stock on file. SEC filing
- 2025-11-24 · Watanabe Todd: Larger than 122 of the 123 other insider sales of Common Stock on file. SEC filing
- 2025-11-13 · Krishnamohan Neha: Larger than 118 of the 123 other insider sales of Common Stock on file. SEC filing
- 2025-11-06 · Edwards Larry Todd: Larger than 115 of the 123 other insider sales of Common Stock on file. SEC filing
- 2025-10-28 · Watanabe Todd: Larger than 120 of the 123 other insider sales of Common Stock on file. SEC filing
- 2025-10-02 · Watanabe Todd: Larger than 111 of the 123 other insider sales of Common Stock on file. SEC filing
- 2025-09-04 · Matsuda Masaru: Larger than 116 of the 123 other insider sales of Common Stock on file. SEC filing
- 2025-07-10 · Burnett Patrick: Larger than 113 of the 123 other insider sales of Common Stock on file. SEC filing
- 2025-05-14 · Heron Patrick J: Larger than 12 of the 13 other insider purchases of Common Stock on file. SEC filing
- 2025-05-09 · Heron Patrick J: Larger than 12 of the 13 other insider purchases of Common Stock on file. SEC filing
- 2025-03-13 · Burnett Patrick: Larger than 121 of the 123 other insider sales of Common Stock on file. SEC filing
- 2025-03-03 · Watanabe Todd Franklin: Larger than 112 of the 123 other insider sales of Common Stock on file. SEC filing
- 2024-11-14 · Burnett Patrick: Larger than all 123 other insider sales of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2024-11-30–2024-11-30: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2024-05-31–2024-05-31: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-17 | Welgus Howard G. · Director | Common Stock | S — Open market or private sale | −635 | 25.67 | SEC filing |
| 2026-06-15 | LIN SUE-JEAN · Director | Common Stock | S — Open market or private sale | −4,946 | 24.38 | SEC filing |
| 2026-06-15 | Welgus Howard G. · Director | Common Stock | S — Open market or private sale | −4,096 | 24.41 | SEC filing |
| 2026-05-11 | Burnett Patrick · See Remarks | Common Stock | S — Open market or private sale | −222 | 21.05 | SEC filing |
| 2026-05-11 | Vairavan Latha · SVP Chief Financial Officer | Common Stock | S — Open market or private sale | −435 | 21.05 | SEC filing |
| 2026-05-04 | Vairavan Latha · SVP Chief Financial Officer | Common Stock | S — Open market or private sale | −1,341 | 23.61 | SEC filing |
| 2026-05-04 | Watanabe Todd · See Remarks | Common Stock | S — Open market or private sale | −3,172 | 23.61 | SEC filing |
| 2026-05-04 | Matsuda Masaru · See Remarks | Common Stock | S — Open market or private sale | −884 | 23.61 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-15 | Welgus Howard G. · Director | Common Stock | M — Exercise or conversion of derivative security | +1,019 | SEC filing |
| 2026-06-15 | Welgus Howard G. · Director | Common Stock | M — Exercise or conversion of derivative security | +822 | SEC filing |
| 2026-06-15 | Welgus Howard G. · Director | Common Stock | M — Exercise or conversion of derivative security | +2,255 | SEC filing |
| 2026-06-15 | Welgus Howard G. · Director | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −2,255 | SEC filing |
| 2026-06-15 | Welgus Howard G. · Director | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −822 | SEC filing |
| 2026-06-15 | Welgus Howard G. · Director | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −1,019 | SEC filing |
| 2026-06-05 | Leonard Keith R · Director | Common Stock | A — Grant, award, or other acquisition | +5,778 | SEC filing |
| 2026-06-05 | LIN SUE-JEAN · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +16,667 | SEC filing |
Showing 8 of 23 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.